These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26167093)

  • 1. Intraductal papillary mucinous neoplasm of the ileal heterotopic pancreas in a patient with hereditary non-polyposis colorectal cancer: A case report.
    Lee SH; Kim WY; Hwang DY; Han HS
    World J Gastroenterol; 2015 Jul; 21(25):7916-20. PubMed ID: 26167093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.
    Flanagan MR; Jayaraj A; Xiong W; Yeh MM; Raskind WH; Pillarisetty VG
    World J Gastroenterol; 2015 Mar; 21(9):2820-5. PubMed ID: 25759555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic intraductal papillary mucinous neoplasm with concomitant heterotopic pancreatic cystic neoplasia of the stomach: a case report and review of the literature.
    Tsapralis D; Charalabopoulos A; Karamitopoulou E; Schizas D; Charalabopoulos K; Liakakos T; Macheras A
    Diagn Pathol; 2010 Jan; 5():4. PubMed ID: 20205774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraductal papillary mucinous neoplasm of the pancreas with loss of mismatch repair in a patient with Lynch syndrome.
    Sparr JA; Bandipalliam P; Redston MS; Syngal S
    Am J Surg Pathol; 2009 Feb; 33(2):309-12. PubMed ID: 18987546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraductal papillary mucinous neoplasm originating from a jejunal heterotopic pancreas: report of a case.
    Okamoto H; Fujishima F; Ishida K; Tsuchida K; Shimizu T; Goto H; Sato A; Satomi S; Sasano H
    Surg Today; 2014 Feb; 44(2):349-53. PubMed ID: 23325495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis index CD105 (endoglin)/CD31 (PECAM-1) as a predictive factor for invasion and proliferation in intraductal papillary mucinous neoplasm (IPMN) of the pancreas.
    Tachezy M; Reichelt U; Melenberg T; Gebauer F; Izbicki JR; Kaifi JT
    Histol Histopathol; 2010 Oct; 25(10):1239-46. PubMed ID: 20712008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An early stage small bowel adenocarcinoma with microsatellite instability phenotype in a case of hereditary nonpolyposis colorectal cancer.
    Furukawa T; Konishi F; Shitoh K; Tsukamoto T; Nagai H
    Int J Colorectal Dis; 2003 May; 18(3):267-70. PubMed ID: 12673494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic micropapillary neoplasm of peribiliary glands with concomitant perihilar cholangiocarcinoma.
    Uchida T; Yamamoto Y; Ito T; Okamura Y; Sugiura T; Uesaka K; Nakanuma Y
    World J Gastroenterol; 2016 Feb; 22(7):2391-7. PubMed ID: 26900302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenocarcinoma arising from heterotopic pancreas at the third portion of the duodenum.
    Fukino N; Oida T; Mimatsu K; Kuboi Y; Kida K
    World J Gastroenterol; 2015 Apr; 21(13):4082-8. PubMed ID: 25852297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinicopathologic and immunohistochemical study of 22 intraductal papillary mucinous neoplasms of the pancreas, with a review of the literature.
    Paal E; Thompson LD; Przygodzki RM; Bratthauer GL; Heffess CS
    Mod Pathol; 1999 May; 12(5):518-28. PubMed ID: 10349991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.
    Banville N; Geraghty R; Fox E; Leahy DT; Green A; Keegan D; Geoghegan J; O'Donoghue D; Hyland J; Sheahan K
    Hum Pathol; 2006 Nov; 37(11):1498-502. PubMed ID: 16996571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Where Did the Colon Cancer Go?
    Marques-de-Sá I; Pita I; Coimbra N; Dinis-Ribeiro M
    Am J Gastroenterol; 2021 Jan; 116(1):10. PubMed ID: 33378315
    [No Abstract]   [Full Text] [Related]  

  • 14. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
    Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
    Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Sebaceous Lesions in a Patient With MUTYH-Associated Polyposis Mimicking Muir-Torre Syndrome.
    Kacerovska D; Drlik L; Slezakova L; Michal M; Stehlik J; Sedivcova M; Hadravsky L; Kazakov DV
    Am J Dermatopathol; 2016 Dec; 38(12):915-923. PubMed ID: 27870730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The contribution of the hereditary nonpolyposis colorectal cancer syndrome to the development of ovarian cancer.
    Malander S; Rambech E; Kristoffersson U; Halvarsson B; Ridderheim M; Borg A; Nilbert M
    Gynecol Oncol; 2006 May; 101(2):238-43. PubMed ID: 16360201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical characteristics and malignant progression of hepatic cystic neoplasms in comparison with pancreatic counterparts.
    Matsubara T; Sato Y; Sasaki M; Harada K; Nomoto K; Tsuneyama K; Nakamura K; Gabata T; Matsui O; Nakanuma Y
    Hum Pathol; 2012 Dec; 43(12):2177-86. PubMed ID: 22705005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: the German Hereditary Nonpolyposis Colorectal Cancer Consortium.
    Plaschke J; Engel C; Krüger S; Holinski-Feder E; Pagenstecher C; Mangold E; Moeslein G; Schulmann K; Gebert J; von Knebel Doeberitz M; Rüschoff J; Loeffler M; Schackert HK
    J Clin Oncol; 2004 Nov; 22(22):4486-94. PubMed ID: 15483016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small-bowel adenocarcinoma diagnosed via capsule endoscopy in a patient found to have hereditary nonpolyposis colorectal cancer.
    Marmo R; Rotondano G; Riccio G; D'Angella R; Rescinito M; Rescinito A; Bianco MA; Cipolletta L
    Gastrointest Endosc; 2007 Mar; 65(3):524-5, discussion 525. PubMed ID: 17208239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.